Goal : Actualité Goal en direct - P4 | Bourse Reflex
Accueil > Tags > Goal

  • Toutes les actualités en rapport avec « Goal »

09/03 09:50 Goal - Shaping the future of the ingredient industry with Naturex

08/03 08:35 Goal - Infra Park expands to Colombia and Panama in collaboration with City Parking

03/02 18:30 Goal - Quantum Genomics Expands U.S. Presence to Advance its Development Programs for Cardiovascular Diseases

27/01 18:40 Goal - GENTICEL REPORTS INITIAL RESULTS AT 12 MONTHS FROM PHASE 2 TRIAL OF HPV IMMUNOTHERAPEUTIC CANDIDATE, GTL001

22/01 17:00 Goal - 2015 REVENUE

20/01 17:50 Goal - 2015 REVENUES

20/11 16:30 Goal - Auplata receives approval to proceed with construction of processing plant in Prefect of French Guiana

19/11 07:00 Goal - Barry Callebaut signs licensing agreement with Naturex to market approved unique 13.5 EFSA health claim on cocoa extracts

16/11 18:30 Goal - Q3 2015 Financial information

16/11 07:00 Goal - 3D Printing: acquisition of Exceltec

04/11 18:15 Goal - Q3 2015 REVENUES - FLEXIBLE COMPOSITE MATERIALS UP 6.2%

03/11 08:00 Goal - FPInnovations and Naturex partnership: Collaborative innovation between two leading players of the Canadian forestry industry and specialty based natural ingredients sector

26/10 17:55 Goal - Dynamic third quarter

21/10 17:55 Goal - THIRD QUARTER RENTAL INCOME

28/09 19:15 Goal - 1st half 2015 : Agreement signed on MPG, and significant advances in 100% bio-based L-Methionine

23/09 07:00 Goal - Prodways signs a major strategic partnership with the Chinese company Farsoon, one of the global leaders in 3D Printing

16/09 16:05 Goal - Green light for the Trans'Alg consortium dedicated to green chemistry and first tranche of funding of EUR 2.4 million from Bpifrance

16/09 16:00 Goal - Fermentalg strengthens its Management team with the appointment of Andrew Echatti as Chief Financial Officer

08/09 18:30 Goal - Successfully restructured and presenting half-year results close to break-even for the first time, Theolia changes its name and becomes FUTUREN

08/09 18:00 Goal - Phase IIa clinical trial for high blood pressure : 50% enrolment four months ahead of schedule and Supervisory Board meeting coming up